Patents by Inventor Christine Delmelle

Christine Delmelle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Patent number: 8580279
    Abstract: The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: November 12, 2013
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Catherine Defrenne, Christine Delmelle, Jean-Louis Ruelle
  • NOVEL COMPOUNDS
    Publication number: 20120328622
    Abstract: The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: June 15, 2012
    Publication date: December 27, 2012
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Catherine Defrenne, Christine Delmelle, Jean-Louis Ruelle
  • BASB082 polynucleotides
    Patent number: 8217159
    Abstract: The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: July 10, 2012
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Catherine Defrenne, Christine Delmelle, Jean-Louis Ruelle
  • BASB082 polynucleotides
    Publication number: 20100184139
    Abstract: The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 22, 2010
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Catherine Defrenne, Christine Delmelle, Jean-Louis Ruelle
  • BASB082 Polypeptides
    Patent number: 7666988
    Abstract: The invention provides BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and polynucleotides encoding BASB082, BASB083, BASB091, BASB092 and BASB101 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: February 23, 2010
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Catherine Defrenne, Christine Delmelle, Jean-Louis Ruelle